Our continued investment in new technologies, processes, people, and skills gives our customers access to innovative new dosage forms and expertise, as well as high-quality products that extend lifecycles and strengthen brands – at an excellent price-performance ratio.

Michael Sibusiso

CEO

Archie Mathare

Head of Legal

Michael Martins

Research & Development

Our development staff have successfully developed and brought effervescent products to market for our clients. Products include Multivitamins effervescent tablets, analgesic, antipyretic and anti-inflammatory.

Our team of scientists combine expertise, integrated services, and specialized technology platforms to develop optimized paediatrics formulations that provide ease of application and improved patient outcomes.